The answer to this is quite simple; it’s called clinical trials and approvals; RAC have only just started this long journey and are still quite a long time away from the approvals, off label prescribing is fraught with danger both from the practitioner side and medical rebates side.
There’s also the cost of trials and associated expenses, at the moment this is another grey area for RAC.
If history is to be followed in the biotech development space RAC is already past the FOMO stage and is in the hiatus stage where the SP will wax and wane for a period of time until new investors can see approvals may be near.
I have been monitoring for a while now and RAC is following the pattern I’ve described, I can see possibly and entry point at around $1.30 odd or a touch lower.
All just IMHO.
General Comments / Chat, page-11095
-
- There are more pages in this discussion • 137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M |
Open | High | Low | Value | Volume |
$1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.56 | 1400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.525 |
1 | 828 | 1.505 |
2 | 4000 | 1.490 |
1 | 38500 | 1.480 |
3 | 22244 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.555 | 1400 | 1 |
1.640 | 1000 | 1 |
1.650 | 14314 | 2 |
1.690 | 585 | 1 |
1.745 | 12000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |